Original BioMedicals Co., Ltd. (TPEX:6483)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
15.05
-0.10 (-0.66%)
Apr 29, 2026, 1:57 PM CST
18.50%
Market Cap 1.01B
Revenue (ttm) 381.00K
Net Income (ttm) -101.51M
Shares Out 66.59M
EPS (ttm) -1.53
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 38,010
Average Volume 257,050
Open 15.10
Previous Close 15.15
Day's Range 14.95 - 15.15
52-Week Range 9.12 - 20.00
Beta 0.34
RSI 44.78
Earnings Date Aug 10, 2026

About Original BioMedicals

Original BioMedicals Co., Ltd., engages in the development of new drugs with non-new ingredients in Taiwan. It develops OBM-A01, for the treatment of acute radiation injury, including nuclear radiation and solar radiation exposed in space; OBM-B01, a cyanide compound drug for protection against toxic gases from fires; and CCM-CL, a cyclic polypeptide antibiotic. The company was founded in 2011 and is based in Tainan City, Taiwan. [Read more]

Sector Healthcare
Founded 2011
Employees 23
Stock Exchange Taipei Exchange
Ticker Symbol 6483
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.